Weekly Market Recap (Dec 8–12, 2025): Materials & Financials Lead; Tech, Comm Services Slip; WBD Takeover Twist

Weekly Market Recap (December 8–12, 2025)

Mixed tape: Dow advanced while Nasdaq slipped as Basic Materials and Financials led but Tech and Comm Services lagged. Hollywood M&A drama, retail leadership changes, and GLP-1 drug momentum drove headlines.

Index Performance (Weekly)

Index Weekly Change
S&P 500−0.28%
Nasdaq−1.49%
Dow Jones+1.51%

Sector Snapshot (1-Week)

Basic Materials
+3.13%
Financial
+2.16%
Industrials
+1.28%
Consumer Defensive
+1.02%
Healthcare
+0.26%
Consumer Cyclical
+0.25%
Real Estate
−0.68%
Utilities
−1.10%
Energy
−1.15%
Technology
−2.19%
Communication Services
−2.77%

AI Picks Performance (Week)

Stock Weekly Return Comment
Micron Technology (MU)−3.34%Semi softness as Tech lagged.
Alphabet (GOOGL)−1.41%Comm Services weakness and risk-off tilt.
Eli Lilly (LLY)+3.00%Positive data on next-gen weight-loss drug.

The Score — Stocks That Defined the Week

  • Warner Bros. Discovery (WBD) / Paramount Skydance (PSKY) / Netflix (NFLX): PSKY launched a $77.9B hostile bid for all of WBD, countering Netflix’s prior $72B agreement for studios+HBO Max; WBD +4.4% Mon.
  • GameStop (GME): Revenue declined while collectibles grew 50% to $256.1M; BTC holdings value slipped; shares −4.2% Wed.
  • Walt Disney (DIS): $1B investment and licensing pact with OpenAI to enable character video generation; shares +2.4% Thu.
  • Campbell’s (CPB): Tariff headwinds in peak soup season; profit/revenue fell despite top-line beat; shares −5.2% Tue.
  • Eli Lilly (LLY): Retatrutide showed up to 28.7% weight loss in study; shares +1.6% Thu (LLY finished week +3%).
  • Lululemon (LULU): CEO Calvin McDonald to step down; interim co-CEOs named; international strength offset Americas softness; shares +9.6% Fri.

Outlook

  • Style watch: Value/cyclicals (Materials/Financials) gaining traction vs. crowded mega-cap Tech.
  • Media deal risk: WBD–NFLX–PSKY saga could raise dispersion in Comm Services.
  • Health/GLP-1: Positive obesity-drug data keeps Pharma leadership in play into year-end.

Key Takeaway

Rotation stayed in focus: Materials and Financials outperformed while Tech and Comm Services fell. Media M&A headlines, retail reshuffles, and Lilly’s drug data drove the week’s biggest single-stock moves.

Week ended December 12, 2025. Data based on your inputs and summaries provided.

Data & Methods: Market indexes from TradingView, sector performance via Finviz, macro data from FRED, and company filings/earnings reports (SEC EDGAR). Charts and commentary are produced using Google Sheets, internal AI workflows, and the author’s analysis pipeline.
Reviewed by Luke, AI Finance Editor
Author avatar

Luke — AI Finance Editor

Luke translates complex markets into beginner-friendly insights using AI-powered tools and real-world experience. Learn more →

Scroll to Top